Prestige Consumer Healthcare, Inc. (PBH)
49.92
+0.72
(+1.46%)
USD |
NYSE |
Oct 16, 16:00
49.94
+0.02
(+0.04%)
After-Hours: 20:00
Prestige Consumer Healthcare Cash from Investing (Quarterly) : -1.064B for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.064B |
| March 31, 2026 | -3.414M |
| December 31, 2025 | -128.56M |
| September 30, 2025 | -2.929M |
| June 30, 2025 | -1.938M |
| March 31, 2025 | -3.479M |
| December 31, 2024 | -9.816M |
| September 30, 2024 | -2.027M |
| June 30, 2024 | -2.13M |
| March 31, 2024 | -15.00M |
| December 31, 2023 | -4.496M |
| September 30, 2023 | -2.934M |
| June 30, 2023 | 2.323M |
| March 31, 2023 | -6.358M |
| December 31, 2022 | -1.803M |
| September 30, 2022 | -2.376M |
| June 30, 2022 | -1.047M |
| March 31, 2022 | -3.293M |
| December 31, 2021 | -20.23M |
| September 30, 2021 | -231.67M |
| June 30, 2021 | -1.323M |
| March 31, 2021 | -4.896M |
| December 31, 2020 | -5.728M |
| September 30, 2020 | -9.066M |
| June 30, 2020 | -2.553M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.265M |
| December 31, 2019 | -2.483M |
| September 30, 2019 | -3.866M |
| June 30, 2019 | -1.956M |
| March 31, 2019 | -3.341M |
| December 31, 2018 | -2.065M |
| September 30, 2018 | 63.31M |
| June 30, 2018 | -2.469M |
| March 31, 2018 | -2.876M |
| December 31, 2017 | -4.871M |
| September 30, 2017 | -2.231M |
| June 30, 2017 | -1.584M |
| March 31, 2017 | -804.88M |
| December 31, 2016 | 59.26M |
| September 30, 2016 | 51.92M |
| June 30, 2016 | -0.895M |
| March 31, 2016 | -228.01M |
| December 31, 2015 | 6.38M |
| September 30, 2015 | -0.903M |
| June 30, 2015 | -0.436M |
| March 31, 2015 | -2.401M |
| December 31, 2014 | 7.68M |
| September 30, 2014 | -732.05M |
| June 30, 2014 | -78.49M |
| March 31, 2014 | -0.106M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 7.094M |
| Phibro Animal Health Corp. | -16.45M |
| Structure Therapeutics, Inc. | 75.10M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 70.79M |
| Cash from Financing (Quarterly) | 1.018B |
| Free Cash Flow | 235.36M |
| Free Cash Flow Per Share (Quarterly) | 1.409 |
| Free Cash Flow to Equity (Quarterly) | -954.92M |
| Free Cash Flow to Firm (Quarterly) | 77.64M |
| Free Cash Flow Yield | 9.79% |